Abstract:Matrine, one of the major active alkaloids isolated from the Sophora alopecuroides L which is a useful Chinese herbal drug, possesses antipyretic, anti-inflammatory, analgesic, and notable antiviral activities, and has been used for the treatment of lipopolysaccharide-induced liver injury. Recently, it was reported that matrine could inhibit the growth of tumor cells. Nitric oxide(NO), a free radical molecule, is involved in numerous physiological and pathological processes. High levels of NO usually are toxic to tumor cells. It was therefore of interest to determine whether the hybrid of matrine and NO donor furoxan would provide a hitherto unknown class of matrine derivatives that possess potent anticancer activity. Herein furoxan-based matrine compounds 11a-11m were designed and synthesized, and their structures were confirmed by MS, IR, H-1 NMR spectra and elemental analysis. All target compounds exhibited expectedly much more stronger anti human hepatocellular carcinoma cells(HepG2 cells) activity than that of parent compound matrine in vivo. Furthermore, compounds 11a-11c, 11h and 11i had stronger cytotoxic activities than that of control 5-flu-orouracil. The concept of designing NO donor-based matrine derivatives that possess potent anticancer activity warrants further investigation.

Novel No-Releasing Plumbagin Derivatives: Design, Synthesis and Evaluation of Antiproliferative Activity

Novel Anticancer Hybrids from Diazen-1-ium-1,2-diolate Nitric Oxide Donor and ROS Inducer Plumbagin: Design, Synthesis and Biological Evaluations

Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin As Potential Anti-Tumor Agents.

Synthesis of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of 1-Oxo-oridonin with Anti-Proliferative Activity

Synthesis and biological evaluation of novel hybrids of phenylsulfonyl furoxan and phenstatin derivatives as potent anti-tumor agents

No-Releasing Enmein-Type Diterpenoid Derivatives With Selective Antiproliferative Activity And Effects On Apoptosis-Related Proteins

Novel NO-releasing Derivatives of Betulinic Acid with Antitumor Activity

Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives

Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.

Synthesis and Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Tetrahydroisoquinoline As Anticancer and Multidrug Resistance Reversal Agents

Novel Anticancer Oridonin Derivatives Possessing a Diazen-1-ium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation and Nitric Oxide Release Studies.

Synthesis and Biological Evaluation of Novel Hybrid Matrine Derivatives As Anticancer Agents

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives As Potent Antitumor Agents

Synthesis and Anti-cancer Activity of Nitric Oxide Donor-based Matrine Derivatives

Design, synthesis and biological evaluation of novel hybrids of quinazoline derivatives and phenylsulfonylfuroxan as potential anti-tumor agents

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Sixalkoxyl Biphenyl Derivatives As Anticancer Agents

Novel furoxan NO-donor pemetrexed derivatives: design, synthesis, and preliminary biological evaluation

Design, Synthesis, and Biological Evaluation of Esculetin-Furoxan-DEAC Ternary Hybrids for Anti-Triple Negative Breast Cancer

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Matrine Derivatives As Anticancer Agents

Hybrids of Phenylsulfonylfuroxan and Coumarin As Potent Antitumor Agents.